Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Roswell Park Cancer Institute
University of Washington
Institute of Hematology & Blood Diseases Hospital, China
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Children's Hospital of Philadelphia
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Comenius University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire de Nice
St. Jude Children's Research Hospital
University of Florida
Princess Maxima Center for Pediatric Oncology
Case Comprehensive Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Murdoch Childrens Research Institute
University of Miami
PedAL BCU, LLC
University of Rochester
Dana-Farber Cancer Institute
St. Justine's Hospital
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver
Northside Hospital, Inc.
University of Arizona
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Geneve TEAM Ambulances
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
University of Chicago
University of Chicago
Karolinska University Hospital
Nationwide Children's Hospital
City of Hope Medical Center
Institute of Hematology & Blood Diseases Hospital, China
University of Kansas Medical Center
Hospital Universitario Dr. Jose E. Gonzalez
St. Jude Children's Research Hospital
King Hussein Cancer Center
City of Hope Medical Center
Roswell Park Cancer Institute